Related Experiment Video

Updated: Jun 21, 2026

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved

Marc C Levesque, Zhijie Zhou, Larry W Moreland

    Arthritis and Rheumatism
    |August 1, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Anti-Nuclear Antibody Screening Using HEp-2 Cells
    13:01

    Anti-Nuclear Antibody Screening Using HEp-2 Cells

    Published on: June 23, 2014

    Related Experiment Videos

    Last Updated: Jun 21, 2026

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
    06:37

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

    Published on: September 15, 2023

    Anti-Nuclear Antibody Screening Using HEp-2 Cells
    13:01

    Anti-Nuclear Antibody Screening Using HEp-2 Cells

    Published on: June 23, 2014

    Related Concept Videos

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

    Articles linked to this work by shared authors, journal, and citation graph.

    Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis.

    International immunopharmacology·2026

    Cross-sensor domain adaptation multi-point monitoring network for mechanical fault diagnosis.

    PloS one·2026

    Prolonging the Triplet Excited-State Lifetime via Tandem Through-Space Conjugation in Tetracationic Cyclophanes for Efficient Metal-Free Photoredox Catalysis.

    Advanced materials (Deerfield Beach, Fla.)·2026

    Soft Hypoxia-Adaptive Bioelectronics Integrating PEDOT:PSS/Polydopamine/Enzyme Biocomposites for Closed-Loop Therapeutics of Chronic Wounds.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Alternating-Polarity Electrolysis Enables Efficient Enantioselective Semipinacol Rearrangement Using Sodium Chloride.

    Journal of the American Chemical Society·2026

    An Interpretable Belief Rule-Based Fault Diagnosis Method for Complex Equipment Considering Linguistic Fuzzy Information.

    Entropy (Basel, Switzerland)·2026

    Regional distribution of adult rheumatologists.

    Arthritis and rheumatism·2013

    Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

    Arthritis and rheumatism·2013

    Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

    Arthritis and rheumatism·2013

    Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

    Arthritis and rheumatism·2013

    2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

    Arthritis and rheumatism·2013

    Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

    Arthritis and rheumatism·2013
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us